Spriet I - Search Results

1

No interference of the 1,3-β-D-glucan containing nutritional supplement ImunixX with the 1,3-β-D-glucan serum test.

Spriet I, Desmet S, Willems L, Lagrou K. Spriet I, et al. Mycoses. 2011 Sep;54(5):e352-3. doi: 10.1111/j.1439-0507.2010.01922.x. Epub 2010 Jul 19. Mycoses. 2011. PMID: 20637053

2

Evaluation of drotrecogin alpha use in a Belgian university hospital.

Spriet I, Meersseman W, Wilmer A, Meyfroidt G, Casteels M, Willems L. Spriet I, et al. Pharm World Sci. 2006 Oct;28(5):290-5. doi: 10.1007/s11096-006-9045-3. Epub 2006 Nov 17. Pharm World Sci. 2006. PMID: 17111246

3

Meropenem -valproic acid interaction in patients with cefepime-associated status epilepticus.

Spriet I, Meersseman W, De Troy E, Wilmer A, Casteels M, Willems L. Spriet I, et al. Am J Health Syst Pharm. 2007 Jan 1;64(1):54-8. doi: 10.2146/ajhp050512. Am J Health Syst Pharm. 2007. PMID: 17189580

4

Interaction between valproate and meropenem: a retrospective study.

Spriet I, Goyens J, Meersseman W, Wilmer A, Willems L, Van Paesschen W. Spriet I, et al. Ann Pharmacother. 2007 Jul;41(7):1130-6. doi: 10.1345/aph.1K079. Epub 2007 Jul 3. Ann Pharmacother. 2007. PMID: 17609232

5

Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.

Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S, Spriet I, Verbeken E, Van Wijngaerden E. Meersseman W, et al. Among authors: spriet i. Am J Respir Crit Care Med. 2008 Jan 1;177(1):27-34. doi: 10.1164/rccm.200704-606OC. Epub 2007 Sep 20. Am J Respir Crit Care Med. 2008. PMID: 17885264

6

Therapeutic drug monitoring of phenytoin in critically ill patients.

von Winckelmann SL, Spriet I, Willems L. von Winckelmann SL, et al. Among authors: spriet i. Pharmacotherapy. 2008 Nov;28(11):1391-400. doi: 10.1592/phco.28.11.1391. Pharmacotherapy. 2008. PMID: 18956999 Review.

7

Mini-series: II. clinical aspects. clinically relevant CYP450-mediated drug interactions in the ICU.

Spriet I, Meersseman W, de Hoon J, von Winckelmann S, Wilmer A, Willems L. Spriet I, et al. Intensive Care Med. 2009 Apr;35(4):603-12. doi: 10.1007/s00134-008-1383-2. Epub 2009 Jan 9. Intensive Care Med. 2009. PMID: 19132344 Review.

8

Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.

Spriet I, Annaert P, Meersseman P, Hermans G, Meersseman W, Verbesselt R, Willems L. Spriet I, et al. J Antimicrob Chemother. 2009 Apr;63(4):767-70. doi: 10.1093/jac/dkp026. Epub 2009 Feb 13. J Antimicrob Chemother. 2009. PMID: 19218271

9

Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study.

Meersseman W, Lagrou K, Spriet I, Maertens J, Verbeken E, Peetermans WE, Van Wijngaerden E. Meersseman W, et al. Among authors: spriet i. Intensive Care Med. 2009 Sep;35(9):1526-31. doi: 10.1007/s00134-009-1482-8. Epub 2009 Apr 9. Intensive Care Med. 2009. PMID: 19357832

10

Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis.

Spriet I, Delaere L, Lagrou K, Peetermans WE, Maertens J, Willems L. Spriet I, et al. J Antimicrob Chemother. 2009 Oct;64(4):877-8. doi: 10.1093/jac/dkp306. Epub 2009 Aug 14. J Antimicrob Chemother. 2009. PMID: 19684077 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters